Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cabana vs Vytora Health

Cabana
Graded #412

Lower grade

vs+15.799999999999997
Vytora Health
Graded #79

Higher grade

The verdict

Vytora Health takes it — 72.3/100 to 56.5/100.

Vytora Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vytora Health is a 50-state-plus-DC telehealth platform offering compounded semaglutide and tirzepatide alongside brand-name Mounjaro and Zepbound, plus NAD+ and sermorelin peptides.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVytora Health +14
45
59
Dose & formulationVytora Health +21
64
85
Clinical oversightVytora Health +20
76
96
Labs & monitoringVytora Health +3
52
55
FulfillmentVytora Health +31
65
96
Contract termsEven
20
20
Cabana · left barVytora Health · right bar

The numbers

MetricCabanaVytora Health
WeighScore56.5/10072.3/100
GradeCC
Scorecard rank#412#79
SemaglutideNot disclosed$180/mo (all doses, compounded)
TirzepatideNot disclosed$249/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
Cabana

Graded #412 · C

Strengths

  • Compounded semaglutide (injection + oral tablet) and tirzepatide injection
  • Membership includes the prescription, provider care, and free shipping — no insurance needed
  • Concierge support model with a dedicated point of contact
  • Async online assessment with licensed-provider review and fast approval

Where it loses points

  • Pricing is not disclosed publicly — only shown after the online assessment
  • Membership fee is non-refundable once paid
  • Compounding pharmacy is not publicly named
Vytora Health

Graded #79 · C

Strengths

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

Where it loses points

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard